Anzeige
Mehr »
Montag, 12.05.2025 - Börsentäglich über 12.000 News
Titan für Raketen, Vanadium für Batterien: Radar-Projekt perfekt für die Industrie-Revolution!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
683 Leser
Artikel bewerten:
(1)

$2.8 Billion Global 3D Printing Medical/Healthcare Market 2016-2022 Featuring 3D Systems, Arcam, Eos, Envisiontec, Materialise" Nano 3D Biosciences, Organovo, Optomec, Renishaw & Stratasys

Finanznachrichten News

DUBLIN, March 30, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "3D Printing Medical/Healthcare Global Market - Forecast to 2022" report to their offering.

The global 3D printing medical/healthcare market is expected to reach $2,841.2 million by 2022

The 3D printing healthcare market is classified based-on category (products, services and materials), process, applications, end-users and geography. In category segment, materials are further classified into metal, polymer, ceramic and others (Donor cells and pharmaceutical material) where, polymer segment is holding major share. Further, the 3D printing healthcare by process is divided into photopolymerization, deposition, fusion and jetting.

3D printing technology is expanding rapidly in medical/healthcare sector with its wide number of applications in medical, implants, drug manufacturing and so on. As patients are benefited by trending 3D printing technology in terms of customization, accuracy and durability, the traditional methods are being replaced.

Now-a-days, lot of research and development work is ongoing in 3D printing medical sector in order to re-shape the healthcare market by bringing advancement in 3D printing technology by developing innovative products day-by-day. At present, 3D printing technology is significantly poised to grow in medicine sector where, the drug toxicity is tested on human tissue instead of animals. 3D printing is being used in pharmaceutical industry where personalized medicines with appropriate dosage size, color and delivery mode are made to improve patient care.

For instance, Spritam an anti-epileptic drug developed by Aprecia pharmaceuticals using 3D printing technology has undergone trials and is set to be launched in early 2016. Transplantation of 3D printed organs such as heart, liver, ear into human body has emerged since few years and also embryonic stem cells are being generated by 3D printing technology.

Application sector is classified into implant (dental, orthopedic, hearing aid and others), tissue engineering, surgical guides, surgical instruments, pharmaceutical applications, whereas, end-users is segmented into hospitals, biotech & pharmaceutical companies, academic institutions and others (CROs). Geography is divided into North America, Europe, Asia-Pacific and Rest of the world (RoW).

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 3D Printing Healthcare Global Market, By Category

4.1 Introduction

4.2 Products

4.3 Services

4.4 Materials

5 3D Printing Healthcare Global Market, By Process 5.1 Introduction 5.2 Photopolymerization 5.3 Deposition 5.4 Fusion 5.5 Jetting

6 3D Printing Healthcare Global Market, By Application

6.1 Introduction

6.2 Implants & Prosthetics

6.3 Tissue Engineering

6.4 Surgical Instruments

6.5 Surgical Guides

6.6 Pharmaceutical Applications

7 3D Printing Healthcare Global Market, By End Users 7.1 Introduction 7.2 Hospitals 7.3 Biotechnology And Pharmaceutical Industries 7.4 Academic Institutes 7.5 Others

8 3 D Printing Healthcare Global Market, By Geography

9 Competitive Landscape

10 Company Profiles

10.1 3D Systems

10.2 Arcam Ab

10.3 Eos

10.4 Envisiontec

10.5 Materialise Nv

10.6 Nano 3D Biosciences, Inc

10.7 Organovo

10.8 Optomec

10.9 Renishaw

10.10 Stratasys

Companies Mentioned

- 3D Bioprinting Solutions - 3D Systems - Adaptive 3D - Additively Ag - Advanced Prototype - Ak Medical - Aprecia Pharmaceuticals - Arcam Ab - Aspect Biosystems - Atomic Filament - Biobots - Botfeeder - Cae Healthcare - Camplex - Cellink - Confirmis - Cyfuse Biomedical - Dimension Polymers - Eastman 3D Solutions - Embody Orthopedic Limited - Envisiontec - Eos - Exone - Fit Production - Formlabs - Imaginarium - Indeigogo - Layerwise - Materialise - Medshape - Mimedis Ag - Mobelife - Morgan Advanced Ceramics - Morgan Electro Ceramics - Morgan Technical Ceramics - Nanoscribe Gmbh - Natureworks - Novabeans - Optomec - Organovo - Oxford Performance Materials - Pandoram Technologies - Phonax - Poietis - Printelize - Rapid 3D - Renishaw - Revotek - Rokit - Roosterbio - Sculpteo - Shapeways - Sirona - Skinprint - Slm Solutions - Sonova - Stratasys - Tetra - Tevido Biodevices - Texas Instruments - Think3D - Tissue Regeneration System - Vetct - Whiteclouds - Worrel Design

For more information visit http://www.researchandmarkets.com/research/ws2sxd/3d_printing

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

© 2016 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.